Sort
51,593 grants matching “hepatitis”
Investigation of genetic and physiological causes of inherited Vascular and Metab
$413,750Arya Mani · Yale University · R01 · FY2011 · HL
Xanthine oxidase inhibition raises intracellular purines to activate AMPK, improve glucose control and decrease fatty liver and atherosclerosis in type 2 diabetes
$413,750Steven E Shoelson · Joslin Diabetes Center · R01 · FY2016 · DK
The genetics and pathophysiology of impaired Wnt signaling in metabolic syndrome
$413,750Arya Mani · Yale University · R01 · FY2009 · HL
Xanthine oxidase inhibition raises intracellular purines to activate AMPK, improve glucose control and decrease fatty liver and atherosclerosis in type 2 diabetes
$413,750Steven E Shoelson · Joslin Diabetes Center · R01 · FY2017 · DK
Xanthine oxidase inhibition raises intracellular purines to activate AMPK, improve glucose control and decrease fatty liver and atherosclerosis in type 2 diabetes
$413,750Steven E Shoelson · Joslin Diabetes Center · R01 · FY2018 · DK
Molecular determinants of hepatitis C virus infectivity
$413,750Brett D. Lindenbach · Yale University · R01 · FY2009 · AI
The genetics and pathophysiology of impaired Wnt signaling in metabolic syndrome
$413,750Arya Mani · Yale University · R01 · FY2011 · HL
The genetics and pathophysiology of impaired Wnt signaling in metabolic syndrome
$413,750Arya Mani · Yale University · R01 · FY2010 · HL
Investigation of genetic and physiological causes of inherited Vascular and Metab
$413,750Arya Mani · Yale University · R01 · FY2009 · HL
Mechanism of Insulin Resistance in the Aged.
$413,750Kitt F Petersen · Yale University · R56 · FY2009 · AG
Beta Adrenergic Blockade and Insulin Sensitivity
$413,730Robert R Wolfe · University Of Texas Med Br Galveston · P50 · FY2007 · GM
Novel Liver Signaling Pathways Controlling Adiposity
$413,714Terry D Hinds · University Of Kentucky · R01 · FY2023 · DK
Glycopathology of HCC: identification of the source cells of serum fucosylation
$413,676Anand S Mehta · Medical University Of South Carolina · U01 · FY2021 · CA
Noninvasive Portal Pressure Measurements in Children
$413,666Flemming Forsberg · Thomas Jefferson University · R01 · FY2018 · DK
Carbohydrate-Mediated Platelet Clearance
$413,650Karin Maria Hoffmeister · Brigham And Women'S Hospital · R01 · FY2015 · HL
miR-378/378* promotes hepatic lipid accumulation and progression of NAFLD to NASH
$413,641Guisheng Song · University Of Minnesota · R01 · FY2018 · DK
miR-378/378* promotes hepatic lipid accumulation and progression of NAFLD to NASH
$413,641Guisheng Song · University Of Minnesota · R01 · FY2016 · DK
miR-378/378* promotes hepatic lipid accumulation and progression of NAFLD to NASH
$413,641Guisheng Song · University Of Minnesota · R01 · FY2017 · DK
miR-378/378* promotes hepatic lipid accumulation and progression of NAFLD to NASH
$413,641Guisheng Song · University Of Minnesota · R01 · FY2015 · DK
Mechanisms of hepatitis C virus persistence
$413,600Arash Grakoui · Emory University · R01 · FY2013 · AI
Adapt IFCBT into HIV Prevention Intervention
$413,571Johns Hopkins University · R01 · FY2005 · DA
Cell Recruitment Induced by ECM Scaffold Degradation
$413,570Stephen F. Badylak · University Of Pittsburgh At Pittsburgh · R01 · FY2009 · AR
Mechanisms of Liver Toxicity of Anit-Depressant Duloxetine
$413,566Feng Li · Baylor College Of Medicine · R01 · FY2021 · DK
HBV Research Network Database Protocol and Clinical Trial Study Proposals
$413,503Steven-Huy B Han · University Of California Los Angeles · U01 · FY2009 · DK
ANALYSIS OF INTRAHEPATIC MACROPHAGE PROFILES FOR PREDICTING RISK OF FIBROSIS DEVELOPMENT IN PATIENTS WITH DIFFERENT TYPES OF CHRONIC LIVER DISEASE
$413,478Heather L Stevenson · University Of Texas Med Br Galveston · R01 · FY2024 · DK